BCAX SG&A Expense Growth
Bicara Therapeutics Inc · SG&A Expense Growth
BCAX SG&A Expense Growth
Latest reported62.54%period ending
BCAX FY SG&A Growth (YoY) (0.00% → 62.54%)
Latest values, visible window
High-resolution chart · PNG
BCAX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 62.536% | |
| 102.4374% | |
| 46.1538% | |
| 0% |